Neokay (Phytomenadione)

Phytomenadione, the active ingredient in Neokay, is a vitamin K presented as an oral preparation for oral use. It is employed to correct vitamin K deficiency‑related bleeding, to prevent and treat hemorrhage in newborns, and to reverse the anticoagulant effects of warfarin and other vitamin K antagonists.

GNH USA supplies Neokay as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neokay is a vitamin K used to manage disorders of coagulation and related bleeding risks.

- Vitamin K deficiency: restores normal clotting factor activity and stops bleeding. - Newborn hemorrhage: prevents and treats bleeding in neonates due to low vitamin K stores. - Warfarin reversal: counteracts anticoagulation caused by warfarin or other vitamin K antagonists.

Adverse reactions may occur with oral vitamin K therapy and should be monitored.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools occurring shortly after dosing. - Abdominal pain: transient discomfort in the stomach area. - Flushing: temporary redness of the skin. - Headache: mild to moderate head pain. - Dizziness: occasional light‑headed sensation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hemolysis: breakdown of red blood cells, presenting with fatigue and jaundice. - Severe allergic reaction: rash, itching, swelling of face or throat. - Elevated liver enzymes: indication of hepatic stress. - Thrombosis: formation of abnormal blood clots. - Hypotension: sudden drop in blood pressure.

When prescribing Neokay, consider the following safety measures. - Assess vitamin K status: evaluate baseline coagulation parameters before initiation. - Monitor anticoagulation: check INR or PT values regularly in patients on warfarin. - Use with caution in liver disease: impaired synthesis of clotting factors may affect response. - Avoid in known hypersensitivity: discontinue if allergic reactions develop. - Pregnancy considerations: only use if the potential benefit outweighs risk to the fetus. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Neokay can interact with several medications that affect coagulation pathways.

Major Interactions (Avoid): - Warfarin: may markedly reduce anticoagulant effect, leading to clot formation. - Broad‑spectrum antibiotics: can alter gut flora and reduce vitamin K synthesis, enhancing Neokay effect. - High‑dose vitamin E: may antagonize vitamin K activity, decreasing efficacy.

Moderate Interactions (Monitor Closely): - Other anticoagulants (e.g., direct oral anticoagulants): may require dose adjustment. - Lipid‑lowering agents (e.g., statins): occasional reports of altered coagulation parameters. - Herbal supplements containing coumarin: potential additive effect on vitamin K pathways.